Blue test tubes arranged in a line, disappearing into the background

Drug news

Moventig is launched in UK for treatment of opioid-induced constipation- AstraZeneca

Read time: 1 mins

Last updated:9th Oct 2015

Published:9th Oct 2015

Source: Pharmawand

Moventig (naloxegol) from AstraZeneca was approved in the EU on 8 December 2014 for treatment of opioid-induced constipation in adult patients who had an inadequate response to laxatives. In July 2015 the drug was recommended by the National Institute for Health and Care Excellence (NICE) and AstraZeneca has now announced that it has been launched in the United Kingdom.

How do you prefer to access medical updates and information?

Listen to a podcast

Watch a video

Read an article

Other

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view